– Executive Leadership Team Brings Diverse Skills and Broad Expertise to New Venture – RESEARCH TRIANGLE PARK, N.C., March 30, 2022 – Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class therapies for patients with chronic kidney disease (CKD), today announced the executive leadership team …